 |
Products |  |
Diseases | | Products |
|
Trials |  |
News |  |
- ||| ATH-63 / Athos Therap
Trial completion: Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects (clinicaltrials.gov) - May 3, 2024
P1, N=76, Completed, Sponsor: Athos Therapeutics Inc
Recruiting --> Completed
- | ATH-63 / Athos Therap
Enrollment open: Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects (clinicaltrials.gov) - Apr 12, 2023
P1, N=76, Recruiting, Sponsor: Athos Therapeutics Inc
Recruiting --> Completed Not yet recruiting --> Recruiting
- | ATH-63 / Athos Therap
New P1 trial: Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ATH-063 in Healthy Subjects (clinicaltrials.gov) - Apr 11, 2023
P1, N=76, Not yet recruiting, Sponsor: Athos Therapeutics Inc